Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01504204 · ClinicalTrials.gov registry record · Phase 4
Effect of Samples on Acne Treatment With Epiduo® Gel
A Phase 4 study, sponsored by Wake Forest University.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT01504204 is a Phase 4 study that has completed, run by Wake Forest University. The registered enrollment target is 20 participants.
The verdict
NCT01504204, a Phase 4 study, has completed, sponsored by Wake Forest University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to compare adherence to treatment and efficacy with Epiduo® Gel in patients with mild to moderate acne who receive a medication sample and instructions on proper application with their stock size medication tube versus patients who receive only the stock size medication tube.
Interventions
- DRUG Adapalene + benzoyl peroxide samples
- DRUG Adapalene + benzoyl peroxide from standard tube
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-12 |
| Est. Completion | 2012-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01504204
The ClinicalTrials.gov registry entry for NCT01504204 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University, which has 100 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Adapalene + benzoyl peroxide samples is the first listed.
NCT01504204 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01504204 about?
NCT01504204 is a clinical study titled "Effect of Samples on Acne Treatment With Epiduo® Gel". The purpose of this study is to compare adherence to treatment and efficacy with Epiduo® Gel in patients with mild to moderate acne who receive a medication sample and instructions on proper application with their stock size medication tube versus patients who receive only the stock size medication ...
What is the current status of trial NCT01504204?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2011-12. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01504204?
The interventions under investigation include: Adapalene + benzoyl peroxide samples (DRUG), Adapalene + benzoyl peroxide from standard tube (DRUG).
Who is sponsoring clinical trial NCT01504204?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.